New gene therapies that can come with a one-time cost of more than $2 million also are having an impact, insurance brokers ...

Regular blood testing to check for toxicity from standard rheumatoid arthritis drugs is recommended. Results of this ...

Across 99 studies examining the effects of high-concentration THC products on mental health outcomes, 70% of the ...

The PCSK9 inhibitor evolocumab (Repatha) got the FDA's blessing for cardiovascular protection, with or without a history of cardiovascular disease (CVD).